. avexis Turns to CatalentPharma\'s ParagonBio for Additional GeneTherapy Manufacturing Capacity httpow.lyyNtM50v2d9gÂpic.twitter.com4VjE5ALE3C

. @avexis Turns to @CatalentPharma's @ParagonBio for Additional #GeneTherapy Manufacturing Capacity: http://ow.ly/yNtM50v2d9g pic.twitter.com/4VjE5ALE3C

17:25 EDT 20 Jul 2019 | Genetic Engineering News

. @avexis Turns to @CatalentPharma's @ParagonBio for Additional #GeneTherapy Manufacturing Capacity: http://ow.ly/yNtM50v2d9g  pic.twitter.com/4VjE5ALE3C

More From BioPortfolio on ". @avexis Turns to @CatalentPharma's @ParagonBio for Additional #GeneTherapy Manufacturing Capacity: http://ow.ly/yNtM50v2d9g pic.twitter.com/4VjE5ALE3C"